News

Article

Sensor Technology Aims to Improve Medication Adherence

Sensors and devices being developed by nGageIT Digital Health Solutions can track patient use of oral solid-dosage or injectable drugs.

Article updated Sept. 5, 2019

Nano-enabled technology and sensor platforms from nGageIT Digital Health Solutions will allow verification that medications are ingested correctly, and on schedule, using a smart phone, said the company in a March 2018 press release. Technologies include a nanoparticle that can be added to oral solid-dosage drug coatings.

The sensor technologies monitor when patients take either oral medications. These data are automatically uploaded to the cloud through the patient’s smart phone and can be tracked in real-time by healthcare providers and in clinical trials, which will lead to better compliance with medical advice and medical device use. Patients can automate complex dosing schedules, and physicians can use medication usage data to precisely customize therapy.

The company’s NanoSmart oral encoding platform includes encoding particles and the NanoSmart Biosensor. The biosensor detects digitally encoded nanoparticles from the patient’s breath using a detection device called the Noz. The NanoSmart encoding particles can be integrated into current oral dosage coatings.

Source: nGageIT Digital Health Solutions 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content